Minapharm Pharmaceuticals (MIPH.CA) - Auditor's Report
Company Name : Minapharm Pharmaceuticals
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
With reference to the standalone financial statements for the financial period ended on 31/03/2026, attached is the limited review report of the standalone financial statements of Al-Mazzawi & Partners.
Auditor's Report (173 KB)
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
With reference to the standalone financial statements for the financial period ended on 31/03/2026, attached is the limited review report of the standalone financial statements of Al-Mazzawi & Partners.
Auditor's Report (173 KB)
Comments